Gainers
- Dermata Therapeutics DRMA stock increased by 28.63% to $5.66 during Monday's after-market session. The market value of their outstanding shares is at $47.1 million.
- Paratek Pharmaceuticals PRTK stock increased by 7.11% to $5.12. The market value of their outstanding shares is at $249.8 million.
- Viracta Therapeutics VIRX shares moved upwards by 4.79% to $6.56. The company's market cap stands at $244.2 million.
- Calithera Biosciences CALA shares rose 2.98% to $2.07. Calithera Biosciences's trading volume hit 270.3K shares by close, accounting for 48.6% of its average volume over the last 100 days. The company's market cap stands at $153.4 million.
- Universe Pharmaceuticals UPC stock increased by 2.65% to $2.32. The market value of their outstanding shares is at $50.4 million.
- Nektar Therapeutics NKTR stock increased by 2.14% to $16.68. Trading volume for this security closed at 132.7K, accounting for 15.33% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $3.0 billion.
Losers
- Phathom Pharmaceuticals PHAT stock declined by 4.63% to $26.0 during Monday's after-market session. The market value of their outstanding shares is at $815.2 million.
- China SXT Pharmaceuticals SXTC stock fell 2.92% to $0.99. The company's market cap stands at $15.3 million.
- Voyager Therapeutics VYGR shares decreased by 2.86% to $4.42. The company's market cap stands at $167.6 million.
- OpGen OPGN stock decreased by 2.44% to $2.0. The market value of their outstanding shares is at $76.5 million.
- Sema4 Holdings SMFR shares declined by 2.18% to $7.19. The company's market cap stands at $1.7 billion.
- Midatech Pharma MTP shares decreased by 2.18% to $1.8. The market value of their outstanding shares is at $22.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in